Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1

OBJECTIVES: Gemcitabine is a standard treatment for advanced pancreatic cancer patients but can cause chemoresistance during treatment. The chemoresistant cells have features of cancer stem cells (CSCs). Resveratrol has been reported to overcome the resistance induced by gemcitabine. However, the me...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cell Prolif
Glavni autori: Zhou, Cancan, Qian, Weikun, Ma, Jiguang, Cheng, Liang, Jiang, Zhengdong, Yan, Bin, Li, Jie, Duan, Wanxing, Sun, Liankang, Cao, Junyu, Wang, Fengfei, Wu, Erxi, Wu, Zheng, Ma, Qingyong, Li, Xuqi
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430460/
https://ncbi.nlm.nih.gov/pubmed/30341797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12514
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items